Roche
ROG.SW
A$489.30
Share price
-0.96%
Change (1 day)
17.56%
Change (1 year)
Categories
Market capitalization of Roche (ROG.SW)
Market cap: A$392.58 Billion
As of June 2025 Roche has a market cap of A$392.58 Billion. This makes Roche the world's 44th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Roche from 2006 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | A$392.58 B | 8.24% |
| 2024 | A$362.70 B | 5.58% |
| 2023 | A$343.53 B | -9.93% |
| 2022 | A$381.41 B | -23.11% |
| 2021 | A$496.06 B | 27.48% |
| 2020 | A$389.12 B | -1.42% |
| 2019 | A$394.71 B | 32.01% |
| 2018 | A$299.00 B | 8.64% |
| 2017 | A$275.22 B | 1.35% |
| 2016 | A$271.55 B | -17.03% |
| 2015 | A$327.27 B | 15.62% |
| 2014 | A$283.06 B | 6.02% |
| 2013 | A$266.99 B | -12.05% |
| 2012 | A$303.56 B | 111.29% |
| 2011 | A$143.67 B | 14.51% |
| 2010 | A$125.46 B | -24.28% |
| 2009 | A$165.70 B | -13.62% |
| 2008 | A$191.82 B | 10.7% |
| 2007 | A$173.28 B | -11.6% |
| 2006 | A$196.03 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | A$561.32 B | 42.98% | 🇺🇸 USA |
 Merck MRK | A$307.41 B | -21.69% | 🇺🇸 USA |
 Pfizer PFE | A$209.99 B | -46.51% | 🇺🇸 USA |
 Sanofi SNY | A$185.13 B | -52.84% | 🇫🇷 France |
 Novartis NVS | A$356.64 B | -9.15% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | A$123.54 B | -68.53% | 🇬🇧 UK |
 Abbott Laboratories ABT | A$356.41 B | -9.21% | 🇺🇸 USA |
 Amgen AMGN | A$241.37 B | -38.52% | 🇺🇸 USA |
 Becton Dickinson BDX | A$75.00 B | -80.89% | 🇺🇸 USA |